Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

被引：6
|
作者：
Lin, Hung-Yao [1 ]
Tseng, Tai-Chung [1 ,2 ,3 ]
机构：
[1] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Med Res, 1 Chang Te St, Taipei 10002, Taiwan
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2022年 / 28卷 / 02期
关键词：
Tenofovir disoproxil fumarate; Tenofovir alafenamide; Hyperlipidemias; Tenofovir;
D O I：
10.3350/cmh.2022.0028
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [31] Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
    Lin, Shenglong
    Huang, Wanlong
    Liao, Ziyuan
    Ma, Huaxi
    Wu, Wenjun
    Lin, Minghua
    Huang, Defu
    Gao, Haibing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [32] Breastmilk pharmacokinetics of tenofovir alafenamide in the setting of chronic hepatitis B infection
    Kayes, T.
    Crane, H.
    Symonds, A.
    Di Girolamo, J.
    Manandhar, S.
    Dumond, J.
    Kashuba, A.
    Lim, T. H.
    Gane, E.
    Levy, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 35 - 35
  • [33] Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alaine Aminotransferase and Positive Hepatitis B Virus DNA
    Gao, Wen-Kang
    Shu, Yan-Yun
    Chen, Yue
    Ai, Yan
    Yang, Xiao-Qian
    Du, Fan
    Ye, Jin
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 112 - 119
  • [34] No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B
    Chan, Henry Lik-Yuen
    Marcellin, Patrick
    Pan, Calvin Q.
    Cathcart, Andrea L.
    Bhardwaj, Neeru
    Liu, Yang
    Cox, Stephanie
    Parhy, Bandita
    Zhou, Eric
    Flaherty, John F.
    Miller, Michael D.
    Gaggar, Anuj
    Shalimar
    Izumi, Namiki
    Lim, Young-Suk
    HEPATOLOGY, 2017, 66 : 11A - 11A
  • [35] Review: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data
    Lim, Young-Suk
    Seto, Wai-Kay
    Kurosaki, Masayuki
    Fung, Scott
    Kao, Jia-Horng
    Hou, Jinlin
    Gordon, Stuart C.
    Flaherty, John F.
    Yee, Leland J.
    Zhao, Yang
    Agarwal, Kosh
    Lampertico, Pietro
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 921 - 943
  • [36] First Real World Experience of Prescribing Tenofovir Alafenamide for Chronic Hepatitis B Patients in Germany
    Petersen, Jorg
    Hoffmann, Christian
    Rieke, Ansgar
    Zu Siederdissen, Christoph Hoener
    Hinrichsen, Holger M.
    Hofmann, Wolf Peter
    Simon, Karl-Georg
    van Boemmel, Florian
    Vermehren, Johannes
    Teuber, Gerlinde
    Degen, Olaf
    Weigand, Kilian
    Antoni, Christoph
    Dikopoulos, Nektarius
    Christensen, Stefan
    Stein, Kerstin
    Wedemeyer, Heiner
    Spengler, Ulrich
    Adel, Susan
    Buggisch, Peter
    HEPATOLOGY, 2018, 68 : 271A - 271A
  • [37] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE AFTER SWITCHING FROM ENTECAVIR IN PATIENTS WITH CHRONIC HEPATITIS B
    Hann, Hie-Won L.
    Park, Grace
    Bin Park, Kyong
    Juon, Hee-Soon
    HEPATOLOGY, 2021, 74 : 480A - 480A
  • [38] Therapeutic effectiveness analysis of tenofovir alafenamide and tenofovir disoproxil fumarate on the treatment for chronic hepatitis B
    Liu, Rui
    Qiao, Jin
    Zhang, Lin
    Dou, Zhihua
    MEDICINE, 2024, 103 (20) : E37953
  • [39] Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Nishikawa, Tomohiro
    Matsui, Masahiro
    Onishi, Saori
    Ushiro, Kosuke
    Asai, Akira
    Kim, Soo-Ki
    Nishikawa, Hiroki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [40] COMPARABLE RISK OF RENAL DYSFUNCTION BETWEEN ENTECAVIR AND TENOFOVIR ALAFENAMIDE IN PATIENTS WITH CHRONIC HEPATITIS B
    Yang, Jiwon
    Lee, Yeojin
    Hong, Hyeyeon
    Chung, Sung Won
    Cho, Minjoo
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    HEPATOLOGY, 2023, 78 : S510 - S510
12345